Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
ABBVIE LIMITED,Atogepant,Chronic migraine prevention,Atogepant (AQUIPTA),Options for investment,Community and Hospital,Nervous System
